Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Sonrotoclax toxicity and degraders' future
Rogers expects sonrotoclax toxicities similar to venetoclax; BTK degraders show strong activity in heavily pretreated CLL.
Play episode from 48:15
Transcript
